ArticleFrontiers in medicine2026
Marked effect of topical application of Chinese medicine combined with moxibustion in a case of refractory malignant ascites in diffuse liver cancer.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although diffuse hepatocellular carcinoma (HCC) is rarely encountered in clinical practice, it frequently leads to the refractory complication of malignant ascites. Conventional treatments such as diuretics, therapeutic paracentesis, and intraperitoneal chemotherapy often yield suboptimal outcomes. Case presentation: We report a detailed case of a 55-year-old female patient with diffuse HCC (CNLC stage IV, Child-Pugh C), portal vein tumor thrombus, and malignant ascites refractory to diuretics. Following confirmation of the diagnosis, she was treated with a novel approach: topical application of a specific herbal paste (containing Asarum sieboldii, Clinical context: To provide broader clinical context, we briefly note the outcomes of three additional patients with advanced HCC and malignant ascites managed during the same period: two who received the same herbal paste with TDP irradiation (without moxibustion) showed stabilization of ascites, while one untreated patient progressed rapidly. Conclusion: This detailed case report demonstrates that topical traditional Chinese medicine (TCM) therapy combined with moxibustion at the Shenque acupoint (CV8) was associated with a marked reduction in refractory malignant ascites in one patient with advanced diffuse hepatocellular carcinoma. The treatment was well-tolerated, with no observed adverse effects, and the patient reported subjective symptom relief and voluntarily continued therapy at home, suggesting good acceptability. This unique, non-invasive, acupoint-specific combinatorial strategy introduces a novel approach worthy of further investigation. While these preliminary findings are hypothesis-generating and supported by contextual observations from three additional patients, they require validation through larger, controlled studies to establish efficacy, safety, and underlying mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.